Tenax Therapeutics (TENX) Receivables - Net (2011 - 2018)

Tenax Therapeutics (TENX) has 8 years of Receivables - Net data on file, last reported at $39286.0 in Q2 2018.

• For the quarter ending Q2 2018, Receivables - Net rose 59.38% year-over-year to $39286.0; the trailing twelve-month figure through Jun 2018 stood at $39286.0 (up 59.38% YoY), and the FY2017 full-year result was $50171.0, down 30.89% from the prior year.
• Receivables - Net held at $39286.0 in Q2 2018, from $39286.0 in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $113184.0 in Q1 2014 to a low of $24648.0 in Q2 2016.
• A 5-year average of $49894.9 and a median of $44291.5 in 2016 frame the typical range for Receivables - Net.
• Across the five-year window, Receivables - Net sank 91.83% in 2014 and jumped 110.34% in 2015, its largest moves.
• Tracing TENX's Receivables - Net over 5 years: stood at $36358.0 in 2014, then surged by 36.0% to $49448.0 in 2015, then soared by 46.82% to $72599.0 in 2016, then tumbled by 30.89% to $50171.0 in 2017, then decreased by 21.7% to $39286.0 in 2018.
• Business Quant data shows TENX's Receivables - Net at $39286.0 in Q2 2018, $39286.0 in Q1 2018, and $50171.0 in Q4 2017.